<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Population-based studies have shown that patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have a higher <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality and an increased <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality compared with non-diabetic subjects </plain></SENT>
<SENT sid="1" pm="."><plain>In non-diabetic subjects, <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> not only has been associated with an increased cardiovascular risk, but is also related with a number of other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>--<z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, and a central body fat distribution--that constitute the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome and are also characteristic of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>After 23 years of follow-up in the Paris Prospective Study, both fasting and 2-h insulin concentrations were related with <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality in a U-shaped fashion, with low and high concentrations being associated with an increased risk, independently of other risk factors; in contrast, while high insulin levels carried an increased risk for cardiovascular and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> mortality, this was not independent of other risk factors </plain></SENT>
</text></document>